The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

Table 4

Postoperative complications of population in our study.

Surgical and pathological features	LAG	OG	value
	N = 77 (%)	N = 76 (%)
Postoperative stays (days)	7.9 ± 2.1	9.3 ± 5.8	0.009
Postoperative complications			0.120
Yes	14 (18.2)	23 (30.3)
No	63 (81.8)	53 (69.7)
Clavien–Dindo classification^#
Grade I	1 (1.3)	1 (1.3)	>0.999
Pulmonary infection	1 (1.3)	1 (1.3)	>0.999
Grade II	12 (15.6)	18 (23.7)	0.207
Pulmonary infection	10 (13.0)	15 (19.7)	0.259
Gastroplegia	0 (0.0)	2 (2.6)	0.245
Digestive tract hemorrhage	0 (0.0)	1 (2.6)	0.497
Intraperitoneal hemorrhage	0 (0.0)	1 (1.3)	0.497
Lymphatic leakage	0 (0.0)	1 (1.3)	0.497
Pancreatic fistula	0 (0.0)	1 (1.3)	0.497
Arrhythmia	1 (1.3)	0 (0.0)	>0.999
Intestinal obstruction	2 (2.6)	0 (0.0)	0.497
Grade IIIa	0 (0.0)	4 (5.3)	0.058
Pulmonary infection	0 (0.0)	4 (5.3)	0.058
Grade IIIb	1 (1.3)	1 (1.3)	>0.999
Anastomotic leakage	0 (0.0)	1 (1.3)	0.497
Intestinal fistula	1 (1.3)	0 (0.0)	>0.999
Grade IV	0 (0.0)	0 (0.0)	NA
Grade V	0 (0.0)	0 (0.0)	NA
Unplanned readmission	1 (1.3)	5 (6.6)	0.116
Pulmonary infection	1 (1.3)	2 (2.6)	0.620
Intestinal obstruction	0 (0.0)	2 (2.6)	0.245
Gastroplegia	0 (0.0)	1 (1.3)	0.497

LAG, laparoscopy-assisted gastrectomy; OG, open gastrectomy; ^#one patient can have more than 1 complication.